Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:17:43 EDT Sun 12 Oct 2025
Enter Symbol
or Name
USA
CA



Q:RGEN - REPLIGEN CORP - https://www.repligen.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RGEN - Q1.3116.63·308.970.1145.24-3.57-2.4931.2134,32913,797148.33  148.955  143.47182.06  102.96518:31:04Aug 2215 min RT 2¢

Recent Trades - Last 10 of 13797
Time ETExPriceChangeVolume
18:31:04Q142.00-6.8110
17:38:55Q142.34-6.4710
17:29:34Q142.44-6.372
17:29:34Q141.17-7.641
17:29:14Q142.44-6.372
16:56:07Q142.00-6.812
16:55:22Q142.44-6.372
16:50:44Q142.91-5.906
16:37:30Q145.24-3.571,100
16:33:47Q145.24-3.57531

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-08-22 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming September Conferences
2025-07-31 07:30U:RGENNews ReleaseRepligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
2025-07-29 07:30U:RGENNews ReleaseRepligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
2025-07-17 07:30U:RGENNews ReleaseRepligen to Report Second Quarter 2025 Financial Results
2025-05-27 07:30U:RGENNews ReleaseRepligen Announces Publication of the Company's 2024 Corporate Sustainability Report
2025-05-22 07:30U:RGENNews ReleaseRepligen Corporation to Present at William Blair Growth Conference
2025-05-07 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming May Investor Conferences
2025-04-29 07:30U:RGENNews ReleaseRepligen Reports First Quarter 2025 Financial Results
2025-04-15 07:30U:RGENNews ReleaseRepligen to Report First Quarter 2025 Financial Results
2025-04-08 07:30U:RGENNews ReleaseRepligen Appoints Jacob Johnson As Vice President Investor Relations
2025-03-04 07:30U:RGENNews ReleaseRepligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
2025-02-20 07:30U:RGENNews ReleaseRepligen Reports Fourth Quarter and Full Year 2024 Financial Results
2025-02-11 07:30U:RGENNews ReleaseRepligen to Report Fourth Quarter and Full Year 2024 Financial Results
2025-01-07 07:30U:RGENNews ReleaseRepligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
2025-01-06 07:30U:RGENNews ReleaseRepligen Launches the CTech(TM) SoloVPE(TM) PLUS System
2024-12-16 08:11U:RGENNews ReleaseBioLife Solutions Appoints Tony J. Hunt to its Board of Directors
2024-12-12 07:30U:RGENNews ReleaseRepligen Announces Publication of the Company's 2023 Corporate Sustainability Report
2024-12-09 07:30U:RGENNews ReleaseRepligen Launches Novel AVIPure(TM) dsRNA Resin in OPUS(TM) Pre-packed Columns
2024-11-12 07:30U:RGENNews ReleaseRepligen Reports Third Quarter 2024 Financial Results
2024-11-05 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming Investor Conferences